Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Application of UPLC-MS/MS to Simultaneously Detect Four Bioactive Compounds in the Tumour-Shrinking Decoction (FM1523) for Uterine Fibroids Treatment
When to Stop Versus When to Continue This is the crucial question
Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)
Alberta Health Services offers comprehensive screening through regional cancer centers
.png)
US$ 28.13
US$ 23.12
US$ 24.34
